Gabriela Plesa
California University of Pennsylvania(US)Parker Institute for Cancer Immunotherapy(US)University of Pennsylvania(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Viral Infectious Diseases and Gene Expression in Insects, Immune Cell Function and Interaction, Biosimilars and Bioanalytical Methods, Immunotherapy and Immune Responses
Most-Cited Works
- → A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma(2017)1,724 cited
- → CRISPR-engineered T cells in patients with refractory cancer(2020)1,396 cited
- → Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV(2014)1,335 cited
- → Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies(2013)849 cited
- → B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma(2019)776 cited
- → Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells(2013)661 cited